MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute My

No advantage for MRD-negative patients in first remission after induction, regardless of <em>FLT3</em> ITD

Related Keywords

United States , Miami , Florida , United Kingdom , London , City Of , American , Mikkael Sekeres , University Of Miami Miller School Medicine , King College London , American Society Of Hematology , Uk National Cancer Research Institute , Jad Othman , American Society , Miami Miller School , Cancer Research Institute , Managing Editor , Medpage Today ,